Published in AIDS Weekly, February 5th, 2007
The active components of VGV-1, Viral Genetics' lead drug candidate based on TNP, were discovered by independent research laboratories and additional studies to confirm these findings are underway.
The compounds identified include two classes of peptides (small protein fragments) that occur naturally in a variety of mammals, including humans. While both have been studied and reported in the scientific literature predominantly as markers, their therapeutic uses have not been actively pursued...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.